Enter your login e-mail to the account
Search
Search parameters
Search results
- New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles )
- Agomelatine – first results from trial VALID in Slovakia
prof. MUDr. Vladimír Novotný, CSc., doc. MUDr. Ján Pečeňák, CSc.
(1/2011, Original articles & case reports ) - Súčasné možnosti a perspektíva liečby negatívnych príznakov schizofrénie
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Zuzana Vančová, PhD.
(2/2018, Review articles )
- Pharmacotherapy of multiple sclerosis in light of the necessary costs associated with prescribing the indicated drug
MUDr. Jiří Slíva, Ph.D.
(4/2018, From the boundary of neurology ) - The role of B lymphocytes in the immunopathogenesis and treatment of multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(3/2024, Informations )
- ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
PharmDr. Dominik Tomek, MPH
(1/2008, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Innovative treatment of chronic lymphocytic leukemia using chemo-free strategies, ringing the bell for chemotherapy?
MUDr. Firas Farkaš, PhD.
(5/2021, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Mantle cell lymhoma and modern therapy – benefit for the patient
MUDr. Tomáš Guman, PhD., MUDr. Monika Hlebašková
(3/2017, Original articles & case reports ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Current treatment options for advanced cholangiocarcinoma
MUDr. Benjamin Špánik, MUDr. Tomáš Šálek, MUDr. Natália Pazderová, MUDr. Eva Zomborská, MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Ján Slopovský, MUDr. Štefan Pörsök, PhD., MPH
(5/2022, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Impact of pricing regulations on access to innovative therapies
Tím Asociácie inovatívneho farmaceutického priemyslu Slovakia, Bratislava
(1/2020, Main topic ) - The aim of QALY in the assessment of cost – effectiveness in oncologic treatment
doc. MUDr. Ján Bielik, CSc., MUDr. Elena Marušáková, MBA
(1/2020, Main topic ) - Large B-cell lymphomas – paradigm 2024
MUDr. Tomáš Guman, PhD., MBA, MUDr. Ján Sýkora
(1/2024, Main topic ) - Clinical research – changes in processes Are there expected changes in research within patients 65 plus?
MUDr. Aurélia Mojzešová, doc. MUDr. Mária Wagnerová, CSc.
(6/2023, Main topic ) - Biosimilars versus a brand name drugs
Prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(5/2018, Review articles )
- New options in the treatment of atopic dermatitis: targeted treatment of moderate to severe forms with innovative drugs
MUDr. Tatiana Hurtová, PhD.
(3/2022, Review articles )
- Natural products for treating symptoms of influenza and flu
Doc. RNDr. Daniela Košťálová, CSc.
(3-4/2015, Phytotherapy ) - New trends in drug forms in therapy of pain
PharmDr. Andrea Gažová, PhD.
(1/2018, Current pharmacotherapy ) - New possibilities extemporaneous preparation in dermatology – innovative foam base Espumil
PharmDr. Sylva Klovrzová, Mgr. Soňa Brtnová, MUDr. Lada Novotná
(2/2017, Extemporaneous preparation of medicines )
- Rivaroxaban (XARELTO) – an orally administered anticoagulant for thromboprophylaxis in orthopedic surgery
doc. MUDr. Otto Mayer, CSc.
(3/2010, Drugs & drug classes )